Anti-Narcolepsy and Anti-Cataplexy Agents - Sedative-Type

"Anti-Narcolepsy and Anti-Cataplexy Agents - Sedative-Type" is a compendial formulary classification rather than a formal FDA-established drug class, primarily encompassing central nervous system depressants such as sodium oxybate and mixed oxybate salts Unlike daytime wakefulness-promoting stimulants, these bedtime sedative medications are believed to exert their therapeutic effects through GABAB receptor agonism, consolidating fragmented nocturnal sleep architecture and augmenting deep, slow-w...

"Anti-Narcolepsy and Anti-Cataplexy Agents - Sedative-Type" is a compendial formulary classification rather than a formal FDA-established drug class, primarily encompassing central nervous system depressants such as sodium oxybate and mixed oxybate salts

Unlike daytime wakefulness-promoting stimulants, these bedtime sedative medications are believed to exert their therapeutic effects through GABAB receptor agonism, consolidating fragmented nocturnal sleep architecture and augmenting deep, slow-wave sleep Clinically, these agents are indicated for the management of cataplexy and excessive daytime sleepiness in patients with narcolepsy, as well as the treatment of idiopathic hypersomnia